171 related articles for article (PubMed ID: 28420450)
1. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication.
Wykes T; Evans J; Paton C; Barnes TRE; Taylor D; Bentall R; Dalton B; Ruffell T; Rose D; Vitoratou S
Psychol Med; 2017 Oct; 47(13):2369-2378. PubMed ID: 28420450
[TBL] [Abstract][Full Text] [Related]
2. Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.
Chen KP; Lung FW
Psychiatr Q; 2017 Dec; 88(4):787-796. PubMed ID: 28150091
[TBL] [Abstract][Full Text] [Related]
3. Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference.
Schouby Bock M; Nørgaard Van Achter O; Dines D; Simonsen Speed M; Correll CU; Mors O; Østergaard SD; Kølbæk P
J Psychopharmacol; 2020 Aug; 34(8):820-828. PubMed ID: 32500804
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia.
Achtyes E; Simmons A; Skabeev A; Levy N; Jiang Y; Marcy P; Weiden PJ
BMC Psychiatry; 2018 Sep; 18(1):292. PubMed ID: 30223804
[TBL] [Abstract][Full Text] [Related]
5. Assessing clinicians' perspectives about the identification and management of antipsychotic medication side-effects: Psychometric evaluation of a survey questionnaire.
Stomski NJ; Morrison P; Meehan T
Int J Ment Health Nurs; 2016 Apr; 25(2):171-9. PubMed ID: 26834074
[TBL] [Abstract][Full Text] [Related]
6. The Patient Assessment Questionnaire: initial validation of a measure of treatment effectiveness for patients with schizophrenia and schizoaffective disorder.
Mojtabai R; Corey-Lisle PK; Ip EH; Kopeykina I; Haeri S; Cohen LJ; Shumaker S
Psychiatry Res; 2012 Dec; 200(2-3):857-66. PubMed ID: 22840524
[TBL] [Abstract][Full Text] [Related]
7. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
[TBL] [Abstract][Full Text] [Related]
8. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
Vernon MK; Revicki DA; Awad AG; Dirani R; Panish J; Canuso CM; Grinspan A; Mannix S; Kalali AH
Schizophr Res; 2010 May; 118(1-3):271-8. PubMed ID: 20172695
[TBL] [Abstract][Full Text] [Related]
9. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders.
Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM
J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628
[TBL] [Abstract][Full Text] [Related]
10. Rating scales to measure side effects of antipsychotic medication: A systematic review.
van Strien AM; Keijsers CJ; Derijks HJ; van Marum RJ
J Psychopharmacol; 2015 Aug; 29(8):857-66. PubMed ID: 26156860
[TBL] [Abstract][Full Text] [Related]
11. A review of self-report medication side effect questionnaires for mental health patients.
Ashoorian D; Davidson R; Rock D; Gudka S; Clifford R
Psychiatry Res; 2014 Nov; 219(3):664-73. PubMed ID: 25034414
[TBL] [Abstract][Full Text] [Related]
12. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
13. Development of Patient-reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL): A novel instrument for medication management.
Sakthong P; Suksanga P; Sakulbumrungsil R; Winit-Watjana W
Res Social Adm Pharm; 2015; 11(3):315-38. PubMed ID: 25453539
[TBL] [Abstract][Full Text] [Related]
14. The development and internal consistency of the satisfaction with Antipsychotic Medication Scale.
Rofail D; Gray R; Gournay K
Psychol Med; 2005 Jul; 35(7):1063-72. PubMed ID: 16045072
[TBL] [Abstract][Full Text] [Related]
15. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.
Atkinson MJ; Sinha A; Hass SL; Colman SS; Kumar RN; Brod M; Rowland CR
Health Qual Life Outcomes; 2004 Feb; 2():12. PubMed ID: 14987333
[TBL] [Abstract][Full Text] [Related]
16. Translation and cultural adaptation of Glasgow Antipsychotic Side-effects Scale (GASS) in Arabic.
AlRuthia Y; Alkofide H; Alosaimi FD; Alkadi H; Alnasser A; Aldahash A; Basalamah A; Alarfaj M
PLoS One; 2018; 13(8):e0201225. PubMed ID: 30138349
[TBL] [Abstract][Full Text] [Related]
17. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
[TBL] [Abstract][Full Text] [Related]
18. Mental health nurses' views about antipsychotic medication side effects.
Stomski NJ; Morrison P; Meehan T
J Psychiatr Ment Health Nurs; 2016 Aug; 23(6-7):369-77. PubMed ID: 27353448
[TBL] [Abstract][Full Text] [Related]
19. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
